Cogent Biosciences (COGT) News Today $4.51 +0.04 (+0.89%) As of 04/24/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Silverarc Capital Management LLC Has $7.19 Million Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)Silverarc Capital Management LLC cut its stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 24.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 921,137 shares of the technology company's stock aftApril 24 at 7:35 AM | marketbeat.comDiadema Partners LP Acquires New Position in Cogent Biosciences, Inc. (NASDAQ:COGT)Diadema Partners LP purchased a new stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 90,000 shares of the technology company's stock, valued at approximately $702,000. Diadema Partners LP owApril 24 at 7:17 AM | marketbeat.comXTX Topco Ltd Takes $457,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT)XTX Topco Ltd acquired a new position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 58,560 shares of the technology company's stock, valued at appApril 23 at 4:13 AM | marketbeat.comCogent Biosciences (NASDAQ:COGT) Trading Down 7.6% - Should You Sell?Cogent Biosciences (NASDAQ:COGT) Trading Down 7.6% - Here's WhyApril 18, 2025 | marketbeat.comWalleye Capital LLC Boosts Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT)Walleye Capital LLC lifted its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 68.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 936,791 shares of the technApril 18, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Shares Up 6.1% - Time to Buy?Cogent Biosciences (NASDAQ:COGT) Stock Price Up 6.1% - Still a Buy?April 17, 2025 | marketbeat.comAlliancebernstein L.P. Buys 382,882 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)Alliancebernstein L.P. lifted its position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 466.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 464,942 shares of the technology companyApril 16, 2025 | marketbeat.comFmr LLC Boosts Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)Fmr LLC grew its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 99.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,569,256 shares of the technology company's stocApril 15, 2025 | marketbeat.comVanguard Group Inc. Purchases 418,975 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)Vanguard Group Inc. grew its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 7.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,133,380 shares of the technology company's stock after buyiApril 14, 2025 | marketbeat.comTrexquant Investment LP Grows Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)Trexquant Investment LP boosted its holdings in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 184.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 277,523 shares of the technology company's stock after buying an additional 179,9April 11, 2025 | marketbeat.comFranklin Resources Inc. Raises Stake in Cogent Biosciences, Inc. (NASDAQ:COGT)Franklin Resources Inc. boosted its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 28.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,283,673 shares of the technology company's stock after buyApril 11, 2025 | marketbeat.comCogent: Several 2025 Readouts On Deck With Bezuclastinib AdvancementApril 9, 2025 | seekingalpha.comCogent Biosciences (NASDAQ:COGT) Sets New 52-Week Low - Time to Sell?Cogent Biosciences (NASDAQ:COGT) Reaches New 52-Week Low - Time to Sell?April 9, 2025 | marketbeat.comSpringhill Fund Asset Management HK Co Ltd Takes $4.28 Million Position in Cogent Biosciences, Inc. (NASDAQ:COGT)Springhill Fund Asset Management HK Co Ltd acquired a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 548,554 shares of the technology company'April 8, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Cinctive Capital Management LPCinctive Capital Management LP trimmed its stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 87.7% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 40,643 shares of the technology company's stock after selling 289,776 shares during the qApril 6, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Reaches New 52-Week Low - Here's WhyCogent Biosciences (NASDAQ:COGT) Hits New 52-Week Low - What's Next?April 2, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Stock Price Down 7.7% - Time to Sell?Cogent Biosciences (NASDAQ:COGT) Shares Down 7.7% - Should You Sell?April 1, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight analysts that are covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, four have issued a buy recMarch 31, 2025 | marketbeat.comWe're Keeping An Eye On Cogent Biosciences' (NASDAQ:COGT) Cash Burn RateMarch 29, 2025 | finance.yahoo.comEntryPoint Capital LLC Acquires Shares of 52,346 Cogent Biosciences, Inc. (NASDAQ:COGT)EntryPoint Capital LLC bought a new position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 52,346 shares of the technology company's stock, valued at approximately $408,000. Other large investors havMarch 27, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Shares Down 5.1% - Here's WhyCogent Biosciences (NASDAQ:COGT) Trading Down 5.1% - What's Next?March 26, 2025 | marketbeat.comCogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual MeetingMarch 25, 2025 | globenewswire.comCogent Biosciences (NASDAQ:COGT) Shares Down 2.3% - Should You Sell?Cogent Biosciences (NASDAQ:COGT) Stock Price Down 2.3% - Should You Sell?March 15, 2025 | marketbeat.comScotiabank Initiates Coverage of Cogent Biosciences (COGT) with Sector Outperform RecommendationMarch 8, 2025 | msn.comCogent Biosciences (NASDAQ:COGT) Shares Down 5.3% - Should You Sell?Cogent Biosciences (NASDAQ:COGT) Stock Price Down 5.3% - Time to Sell?March 8, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Coverage Initiated at ScotiabankScotiabank started coverage on shares of Cogent Biosciences in a research note on Friday. They set a "sector outperform" rating and a $17.00 price target for the company.March 8, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for Cogent Biosciences (COGT)March 7, 2025 | markets.businessinsider.comCogent Biosciences Announces Participation in the Leerink Healthcare ConferenceMarch 7, 2025 | globenewswire.comY Intercept Hong Kong Ltd Purchases 43,472 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)Y Intercept Hong Kong Ltd grew its holdings in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 137.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 75,037 shares of the technology company's stock after purchasing an aMarch 2, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Stock Price Up 7.8% - What's Next?Cogent Biosciences (NASDAQ:COGT) Shares Up 7.8% - Time to Buy?February 28, 2025 | marketbeat.comRobert W. Baird Lowers Cogent Biosciences (NASDAQ:COGT) Price Target to $8.00Robert W. Baird cut their price objective on Cogent Biosciences from $10.00 to $8.00 and set a "neutral" rating for the company in a research note on Thursday.February 28, 2025 | marketbeat.comCogent Biosciences announces expanded results from OLE portion of SUMMIT trialFebruary 27, 2025 | markets.businessinsider.comCogent Biosciences price target lowered to $8 from $10 at BairdFebruary 27, 2025 | markets.businessinsider.comCogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis PatientsFebruary 27, 2025 | globenewswire.comWedbush Research Analysts Boost Earnings Estimates for COGTCogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Equities research analysts at Wedbush lifted their Q1 2025 earnings estimates for shares of Cogent Biosciences in a research report issued to clients and investors on Tuesday, February 25th. Wedbush analyst D. Nierengarten now anticipates thaFebruary 27, 2025 | marketbeat.comNeedham Keeps Their Hold Rating on Cogent Biosciences (COGT)February 26, 2025 | markets.businessinsider.comNeedham & Company LLC Reaffirms "Hold" Rating for Cogent Biosciences (NASDAQ:COGT)Needham & Company LLC restated a "hold" rating on shares of Cogent Biosciences in a research note on Wednesday.February 26, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Earns "Neutral" Rating from WedbushWedbush reissued a "neutral" rating and issued a $11.00 price target on shares of Cogent Biosciences in a report on Tuesday.February 25, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Issues Earnings Results, Beats Expectations By $0.50 EPSCogent Biosciences (NASDAQ:COGT - Get Free Report) posted its quarterly earnings data on Tuesday. The technology company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.59) by $0.50.February 25, 2025 | marketbeat.comCogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial ResultsFebruary 25, 2025 | globenewswire.comCogent Biosciences, Inc. (NASDAQ:COGT) Sees Large Increase in Short InterestCogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) was the target of a large increase in short interest in January. As of January 31st, there was short interest totalling 10,130,000 shares, an increase of 8.3% from the January 15th total of 9,350,000 shares. Based on an average daily volume of 1,590,000 shares, the days-to-cover ratio is presently 6.4 days.February 19, 2025 | marketbeat.comCogent Biosciences (COGT) Projected to Post Earnings on MondayCogent Biosciences (NASDAQ:COGT) will be releasing earnings before the market opens on Monday, February 24, Financial Modeling Prep reports.February 17, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Trading Down 5.9% - What's Next?Cogent Biosciences (NASDAQ:COGT) Shares Down 5.9% - Should You Sell?February 11, 2025 | marketbeat.comCogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual MeetingFebruary 10, 2025 | globenewswire.comLeerink Partnrs Has Optimistic View of COGT FY2025 EarningsCogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Equities researchers at Leerink Partnrs upped their FY2025 earnings estimates for shares of Cogent Biosciences in a research report issued to clients and investors on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now forecasts thFebruary 10, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by BrokeragesCogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven analysts that are currently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the coFebruary 8, 2025 | marketbeat.comResearch Analysts Offer Predictions for COGT Q1 EarningsCogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for shares of Cogent Biosciences in a report released on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the technologyFebruary 7, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Sees Strong Trading Volume - Here's What HappenedCogent Biosciences (NASDAQ:COGT) Sees Unusually-High Trading Volume - Time to Buy?February 6, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Sees Significant Increase in Short InterestCogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 7,980,000 shares, an increase of 9.3% from the December 31st total of 7,300,000 shares. Based on an average daily trading volume, of 1,430,000 shares, the days-to-cover ratio is currently 5.6 days.February 2, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Trading Down 5.3% - Should You Sell?Cogent Biosciences (NASDAQ:COGT) Stock Price Down 5.3% - Here's WhyJanuary 31, 2025 | marketbeat.com Get Cogent Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter. Email Address COGT Media Mentions By Week COGT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COGT News Sentiment▼1.300.73▲Average Medical News Sentiment COGT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COGT Articles This Week▼53▲COGT Articles Average Week Get Cogent Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Schrödinger News Denali Therapeutics News Mirum Pharmaceuticals News Tarsus Pharmaceuticals News Beam Therapeutics News NewAmsterdam Pharma News Kymera Therapeutics News Belite Bio News Bausch Health Companies News Janux Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COGT) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogent Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy COGT Stock Free COGT Stock Alerts